AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From AP Worldstream)
Byline: ANDREW BRIDGES
A pharmaceutical company that seeks federal approval for over-the-counter sales of a prescription diet pill that blocks the absorption of fat faces questions on the pill's potential for creating vitamin deficiencies and encouraging abuse.
Two Food and Drug Administration advisory committees are to discuss on Monday allowing over-the-counter sales of orlistat, which GlaxoSmithKline Consumer Healthcare proposes to market as Alli (pronounced "ally"). That version would be half the dose of the prescription form of the drug, known as Xenical, which won FDA approval in 1999.
An FDA reviewer found the…